BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of rifampicin in urinary tract infections by double blind method]. 1970

K Hayashida, and K Eto, and S Shigematsu

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Hayashida, and K Eto, and S Shigematsu
[Comparison of clinical effect between rifampicin and aminobenzylpenicillin in urinary tract infections by double blind method].
December 1970, Hinyokika kiyo. Acta urologica Japonica,
K Hayashida, and K Eto, and S Shigematsu
Clinical effectiveness of lividomycin on urinary tract infections: evaluation with double-blind method.
December 1973, Current therapeutic research, clinical and experimental,
K Hayashida, and K Eto, and S Shigematsu
Double-blind multicenter trial of a rifampicin-trimethoprim combination and rifampicin alone in urinary tract infections.
January 1979, Chemotherapy,
K Hayashida, and K Eto, and S Shigematsu
Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.
January 1980, Clinical therapeutics,
K Hayashida, and K Eto, and S Shigematsu
[Evaluation by "double-blind" method of a new antibiotic for urinary infections].
August 1972, Revue medicale de Liege,
K Hayashida, and K Eto, and S Shigematsu
[Clinical evaluation of the therapeutic effect of vistamycin and kanamycin on the various urinary tract infections--analysis by double blind method].
March 1972, Hinyokika kiyo. Acta urologica Japonica,
K Hayashida, and K Eto, and S Shigematsu
[Clinical evaluation of rifampicin for urinary tract infection].
June 1971, Hinyokika kiyo. Acta urologica Japonica,
K Hayashida, and K Eto, and S Shigematsu
A double-blind evaluation of ceftizoxime versus cefamandole therapy for urinary tract infections.
November 1982, The Journal of antimicrobial chemotherapy,
K Hayashida, and K Eto, and S Shigematsu
[Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
September 1984, Hinyokika kiyo. Acta urologica Japonica,
K Hayashida, and K Eto, and S Shigematsu
Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
January 1974, Chemotherapy,
Copied contents to your clipboard!